asthma
chronic
respiratori
diseas
whose
preval
increas
western
world
recent
research
begun
focu
role
microbiom
play
asthma
pathogenesi
hope
understand
respiratori
disord
consid
steril
recent
lung
reveal
contain
uniqu
microbiota
shift
toward
molecular
method
quantif
sequenc
microbi
dna
reveal
airway
harbour
uniqu
microbiota
appar
reproduc
differ
present
healthi
diseas
lung
hope
classifi
microbi
load
asthmat
airway
insight
may
afford
possibl
role
pulmonari
microb
may
propag
asthmat
airway
respons
could
potenti
pave
way
new
therapeut
strategi
treatment
chronic
lung
condit
asthma
asthma
seen
stagger
rise
preval
recent
year
million
peopl
worldwid
believ
affect
chronic
respiratori
disord
burden
asthma
felt
global
howev
develop
countri
asthma
come
fore
health
care
concern
incid
rate
asthma
particular
adult
onset
asthma
risen
dramat
respiratori
disord
reach
epidem
proport
incid
childhood
asthma
western
world
also
reach
worri
level
recent
research
begun
focu
role
microb
play
chronic
respiratori
disord
thank
advanc
sequenc
technolog
possibl
dissect
role
microbi
composit
divers
play
multifactori
disord
asthma
begin
becom
clear
clear
differ
present
asthmat
nonasthmat
microbi
load
carri
gain
insight
uniqu
microbiota
asthmat
much
may
reveal
happen
gastrointestin
microbi
research
could
undoubtedli
aid
diseas
prognosi
treatment
research
respiratori
diseas
reward
us
pharmacolog
treatment
inhal
corticosteroid
leukotrien
receptor
antagonist
agonist
recent
target
monoclon
therapi
help
allevi
burden
asthma
sinc
ca
research
confirm
environ
lung
steril
previous
believ
prior
prevail
dogma
bacteria
detect
lower
respiratori
tract
understood
repres
abnorm
health
state
healthi
lung
steril
belief
aros
mainli
due
poor
ineffect
microbi
cultur
techniqu
unabl
replic
lung
habitat
cultur
microb
respiratori
specimen
howev
clear
although
lung
contain
smaller
bacteri
burden
upper
respiratori
tract
distinct
microbiota
present
lower
airway
healthi
individu
find
lung
harbour
uniqu
microbiota
irrespect
health
diseas
led
surg
research
take
place
effort
categoris
distinct
microbiota
diseas
lung
also
healthi
lung
thank
advanc
cultur
independ
techniqu
uniqu
steadi
state
microbiota
lung
elucid
chang
microbi
composit
lower
airway
microbiota
may
connect
chronic
lung
diseas
asthma
develop
inexpens
next
gener
sequenc
techniqu
develop
human
genom
project
sequenc
human
genom
made
possibl
determin
microbi
particular
bacteri
commun
cultur
independ
manner
screen
divers
bacteri
ribosom
rrna
gene
present
biolog
nucleic
acid
sampl
sequenc
databas
develop
bioinformat
algorithm
enabl
organis
interpret
huge
data
set
made
avail
sequenc
machin
metagenom
approach
enabl
far
greater
understand
microb
present
variou
site
role
play
overal
hostmicrobiom
interact
thank
cultur
independ
techniqu
low
level
oral
bacteria
prevotella
veillonella
discov
lower
airway
healthi
individu
surfac
area
direct
exposur
environ
lung
prime
site
microbi
exposur
environment
condit
shape
composit
microbi
commun
habitat
import
understand
environ
lung
fulli
understand
potenti
microb
could
inhabit
locat
see
fig
lung
view
one
standard
habitat
fact
consist
microenviron
differ
temperatur
ph
mucu
product
epitheli
specialis
motil
mucociliari
escal
oxygen
concentr
nutrient
avail
potenti
influenc
varieti
type
microorgan
present
physiochem
properti
gradient
may
plausibl
allow
surviv
differ
microorgan
within
vari
region
airway
note
howev
recent
studi
conclud
lung
healthi
individu
spatial
variat
microbiota
appear
far
less
signific
variat
present
across
individu
author
also
report
microbiota
lung
health
seem
influenc
immigr
elimin
microb
rather
growth
condit
influenc
bacteri
growth
rate
furthermor
pattern
may
revers
patient
advanc
lung
diseas
due
alter
pulmonari
environ
induc
diseas
progress
lung
connect
directli
microbi
rich
oral
nasal
passag
potenti
regular
transloc
microb
site
secondari
inspir
possibl
associ
micro
aspir
therefor
surpris
may
similar
microbi
composit
site
investig
venkataraman
et
al
utilis
neutral
model
commun
ecolog
differenti
member
lung
microbiom
whose
presenc
lung
consist
dispers
bodi
site
member
lung
microbiom
deviat
model
suggest
competit
advantag
microb
lung
studi
dispers
microb
oral
caviti
would
seem
main
mechan
wherebi
lung
becom
colonis
healthi
individu
speci
constantli
deviat
neutral
model
one
might
postul
constant
dispers
import
microbi
structur
lower
lung
rather
select
pressur
howev
process
could
possibl
complex
suggest
neutral
model
possibl
microb
introduc
airway
kill
rate
introduc
creat
homeostat
balanc
therefor
percept
neutral
distribut
fact
lung
environ
highli
select
due
belief
lung
steril
due
invas
natur
bronchoscop
sampl
lower
respiratori
tract
first
includ
human
microbiom
project
recent
characteris
lung
microbiota
reveal
defin
reproduc
differ
healthi
diseas
state
lung
accept
healthi
lung
microbiom
divers
studi
even
shown
respiratori
tract
rapidli
acquir
divers
birth
intestin
accept
microb
present
within
airway
challeng
remain
overcom
difficulti
sampl
cultur
microb
lower
respiratori
tract
valid
sampl
techniqu
bronchoalveolar
lavag
bal
fluid
bronchial
brush
subject
debat
due
potenti
contamin
oropharynx
bronchoscopi
despit
concern
recent
studi
shown
compar
microbi
speci
present
upper
respiratori
tract
microbiota
lower
respiratori
tract
microbiota
within
lower
respiratori
tract
uniqu
recent
studi
bassi
et
al
compar
sampl
healthi
subject
collect
oral
wash
bal
fluid
nasal
swab
gastric
aspir
demonstr
oral
microbiom
contamin
bal
sampl
oral
caviti
stomach
contain
high
speci
rich
highest
bacteri
signal
level
comparison
nasal
caviti
lung
much
lower
bacteri
signal
level
whilst
seen
bacteri
commun
present
healthi
lung
overlap
present
oropharynx
concentr
much
lower
lung
differ
commun
composit
sampl
healthi
lung
sampl
techniqu
concern
regard
contamin
caution
also
taken
sampl
process
gener
analysi
complex
dataset
unintent
environment
contamin
process
lead
unintent
identif
contamin
power
sequenc
technolog
control
potenti
sourc
contamin
fig
factor
influenc
lung
microbiom
schemat
illustr
complex
factor
affect
lung
microbiom
asthma
lung
microenviron
select
specif
microb
chang
asthma
due
environment
factor
infect
treatment
option
modul
inflammatori
cascad
epitheli
interfac
correspond
microbiom
asthmat
display
chang
microbiom
increas
lung
microb
haemophilu
neisseria
moraxella
staphylococcu
streptoccoccu
reduc
veillonella
faecalibacterium
lachospira
rothia
sp
reagent
vital
also
import
avoid
bia
extract
protocol
critic
sequenc
sampl
usual
one
variabl
region
rrna
gene
target
primer
howev
ideal
detect
certain
speci
fungi
rrna
intern
transcrib
spacer
sequenc
repres
appropri
target
viral
identif
requir
approach
markergenedirect
pcr
analysi
effect
lung
microbiom
composit
health
diseas
state
interest
asthma
research
respiratori
diseas
cystic
fibrosi
cf
copd
pulmonari
fibrosi
bronchiectasi
bronchiectasi
believ
chang
composit
lung
microbiota
event
antibiot
therapi
inflamm
may
downstream
consequ
function
immun
system
allow
format
preserv
chronic
infect
lead
microbi
pathogen
appreci
cystic
fibrosi
multisystem
diseas
involv
hepatobiliari
gastrointestin
tract
gastrooesophag
reflux
gor
effect
cf
patient
lung
gastric
microbiom
interdepend
relationship
two
clearli
defin
gastric
sputum
cultur
reveal
patient
cf
one
microorgan
fungal
bacteri
common
two
sampl
among
bacteria
found
two
site
pseudomona
streptococcu
achromobact
pseudomona
aeruginosa
pa
bacteria
typic
associ
cf
found
sputum
sampl
patient
ident
pa
isol
stomach
comparison
non
cf
gastric
juic
sampl
reveal
higher
divers
stomach
microbiom
patient
cf
may
act
potenti
pathogen
reservoir
aerodigest
microbiom
warrant
research
may
imping
pathophysiolog
cf
bile
acid
aspir
comorbid
factor
link
mani
lung
diseas
could
plausibl
shape
lung
microbiom
promot
colonis
pa
cf
patient
use
system
base
analysi
involv
transcriptom
function
genom
immunochemistri
network
gene
involv
virul
adapt
metabol
antibiot
toler
link
bile
respons
pathogen
host
cell
elud
bile
acid
leakag
oesophag
tract
occur
cf
patient
occur
copd
patient
although
figur
thought
underestim
diseas
progress
antibiot
toler
respiratori
patient
may
link
bile
acid
signal
bile
acid
elict
biofilm
behaviour
pseudomona
aeruginosa
increas
polymyxin
macrolid
antibiot
toler
reduc
microbi
biodivers
copd
research
infanc
regard
microbiota
copd
lung
howev
recent
studi
demonstr
diseas
progress
reduct
bacteri
divers
howev
demonstrat
outgrowth
singl
microorgan
case
cf
pseudomona
aeruginosa
predomin
patient
idiopath
pulmonari
fibrosi
ipf
report
higher
rel
abund
haemophilu
streptococcu
neisseria
veillonella
speci
asthma
chronic
inflammatori
diseas
characteris
airway
hyperrespons
lead
intermitt
repeat
bout
wheez
chest
tight
breathless
cough
asthma
complex
heterogen
mani
clinic
phenotyp
whose
vari
express
depend
interplay
numer
environment
factor
along
mani
differ
suscept
gene
airway
epithelium
pivot
inflammatori
respons
host
major
sourc
proinflammatori
mediat
h
cell
subsequ
play
promin
role
allerg
disord
pathogenesi
lead
b
cell
isotyp
switch
gener
ige
antibodi
specif
particular
insult
allergen
h
cell
enlist
enhanc
surviv
eosinophil
mast
cell
induc
goblet
cell
hyperplasia
drive
bronchial
hyper
reactiv
airway
obstruct
characteris
clinic
present
asthma
run
cycl
symptom
free
period
follow
vari
period
exacerb
usual
trigger
stimuli
exacerb
result
worsen
symptom
lung
function
although
gener
revers
follow
return
normal
lung
function
patient
repeat
exacerb
may
lead
new
compromis
baselin
exacerb
trigger
includ
infect
aeroallergen
pollut
drug
physic
stimuli
exacerb
often
treat
vari
combin
increas
inhal
therapi
system
corticosteroid
antibiot
one
might
postul
therefor
exacerb
event
mode
therapi
utilis
treat
event
may
impact
composit
lung
microbiom
inde
recent
studi
demonstr
gut
microbiota
alter
circadian
rhythm
may
open
new
avenu
research
identifi
caus
asthmat
exacerb
note
alter
bmal
clock
gene
bronchiolar
cell
disrupt
circadian
neutrophil
recruit
via
turn
lead
exagger
host
respons
lp
lipopolysaccharid
defici
host
immun
respons
streptococcu
pneumonia
gastrointestin
tract
complex
interplay
symbiot
bacteria
respons
process
nutrient
metabol
host
turn
provid
nutrient
rich
protect
environ
interplay
requir
strict
sequestr
resid
microb
host
lumen
prevent
trigger
process
sepsi
inflamm
epitheli
antimicrobi
protein
play
vital
role
hinder
contact
resid
microb
host
mucos
surfac
germfre
mice
antibiot
treatment
murin
model
demonstr
evid
microbiota
requir
gut
epithelia
develop
function
cash
et
al
first
identifi
role
microb
play
induc
antimicrobi
peptid
epitheli
villu
develop
matur
seen
germfre
mice
microbi
colonis
induc
express
secret
ctype
lectin
known
human
hippap
express
directli
correl
bacteri
express
host
epitheli
contact
preferenti
bind
peptidoglycan
present
gram
posit
bacteria
highlight
hostmicrobi
symbiot
relationship
maintain
therefor
possibl
similar
protect
mechan
could
involv
lung
mucos
epithelium
innat
lymphoid
cell
ilc
emerg
popul
innat
immun
cell
deriv
depend
lymphoid
cell
progenitor
cell
popul
ilc
share
mani
function
development
characterist
cell
popul
ilc
demonstr
involv
orchestr
certain
hostcommens
bacteria
relationship
involv
would
implic
immun
inflamm
tissu
homeostasi
intestin
lung
seen
pathogen
ilc
respons
associ
asthma
airway
hyperrespons
murin
model
commens
bacteria
epitheli
cell
ilc
share
close
proxim
investig
potenti
impact
interact
upon
develop
ilc
take
place
henc
ilc
may
repres
potenti
target
numer
human
diseas
asthma
recent
studi
focus
ilc
also
identifi
key
dialogu
ilc
epithelia
microbiota
iga
predomin
antibodi
mucos
surfac
particular
upper
respiratori
tract
pleiotrop
effect
iga
induc
toler
phenotyp
mucos
surfac
critic
import
mainten
mucos
homeostasi
iga
creat
class
switch
recombin
ig
heavi
chain
iga
offer
import
role
mucos
homeostasi
opsonis
neutralis
pathogen
toxin
result
reduct
antigen
load
mucos
immun
system
iga
mice
protect
role
iga
mucos
surfac
highlight
mice
impair
clearanc
lumin
pathogen
mycobacterium
tuberculosi
streptococcu
pneumonia
citrobact
rodentium
giardia
muri
giardia
lamblia
demonstr
microbiota
act
tolllik
receptor
condit
lung
dendrit
cell
ldc
produc
turn
influenc
product
iga
lung
research
date
focus
mainli
gut
evid
bidirect
link
gut
lung
immun
function
increas
key
featur
microorgan
abil
recognis
sampl
immun
system
ensu
immun
respons
depend
microb
rang
benign
toler
acut
inflamm
injuri
ensu
repair
remodel
lung
respiratori
fungi
bacteria
virus
recognis
innat
receptor
includ
tolllik
receptor
tlr
helicas
nodlik
receptor
stimul
activ
nuclear
factor
b
group
transcript
factor
possibl
result
induct
proinflammatori
host
respons
gene
microorgan
affect
permeabl
epithelium
increas
infect
risk
affect
epitheli
integr
invas
epithelium
cell
lead
cell
death
shed
compromis
epithelium
subsequ
allergen
uptak
effect
environment
exposur
pollut
may
caus
increas
possibl
develop
exacerb
heighten
immun
respons
increas
risk
pathogen
respons
asthma
develop
asthma
patient
increas
risk
bacteri
infect
cultur
depend
independ
techniqu
seen
increas
carriag
pathogen
respiratori
bacteria
birth
cohort
studi
shown
increas
carriag
bacteria
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
earli
life
link
asthma
risk
develop
recurr
wheez
children
born
asthmat
mother
studi
bisgaard
et
al
also
reveal
children
recurr
wheez
first
year
life
wheez
episod
associ
bacteri
viral
infect
equal
suggest
bacteri
viral
infect
may
act
independ
contribut
asthma
symptom
therebi
highlight
import
role
bacteri
infect
independ
viral
infect
pathogenesi
asthma
studi
hilti
et
al
member
phylum
proteobacteria
associ
airway
diseas
asthma
copd
patient
haemophilu
moraxella
neisseria
spp
found
lung
asthmat
patient
strong
correl
increas
asthma
risk
found
oropharynx
neonat
staphylococcu
found
present
airway
children
difficult
asthma
bacteroidet
particular
prevotella
veillonella
spp
found
preval
healthi
control
microorgan
add
onset
progress
atop
asthma
microorgan
also
protect
function
hygien
hypothesi
part
help
explain
disproportion
spread
asthma
western
industrialis
world
propos
repeat
exposur
divers
common
infect
repeat
exposur
environment
microb
childhood
stimul
immun
system
manner
promot
protect
responseagainst
futur
asthma
risk
socal
hygien
hypothesi
contend
exposur
soil
dust
microb
antibiot
vaccin
farm
anim
famili
size
addit
factor
caesarean
section
birth
versu
vagin
birth
exclus
formula
feed
versu
breastfeed
part
determin
asthma
risk
one
metaanalysi
studi
increas
subsequ
risk
asthma
develop
children
born
caesarean
section
use
antiinflammatori
drug
antibiot
significantli
alter
lung
microbiom
chang
microbiom
lung
may
lead
resist
resili
function
redund
perman
alter
microbiom
seen
even
birth
children
expos
antibiot
half
pregnant
women
america
receiv
antibiot
alter
microbiota
transfer
offspr
environment
microbi
exposur
protect
effect
asthma
develop
parsif
gabriela
studi
asthma
atopi
preval
among
children
live
farm
among
children
refer
group
live
farm
examin
studi
children
live
farm
lower
preval
asthma
refer
group
two
larg
scale
observ
studi
would
appear
wider
rang
microbi
exposur
offer
protect
effect
develop
asthma
shown
singl
nucleotid
polymorph
snp
encod
link
develop
asthma
farm
dwell
children
ubiquitinmodifi
enzym
weaken
activ
deubiquitin
key
signal
intermedi
downstream
receptor
tolllik
receptor
tnf
famili
receptor
accept
chronic
exposur
lowdos
endotoxin
farm
dust
convey
protect
effect
develop
hous
dust
mite
hdm
induc
asthma
mice
loss
associ
allergi
asthma
risk
shown
mice
induc
absenc
increas
sensit
hdm
ensu
asthma
seen
sever
children
rural
area
germani
austria
switzerland
farm
nonfarm
household
involv
studi
determin
whether
protect
effect
present
upon
endotoxin
exposur
risk
asthma
atop
wheez
mattress
dust
indic
endotoxin
exposur
examin
found
environment
exposur
endotoxin
associ
develop
toler
toward
ubiquit
allergen
found
natur
environ
muram
acid
compon
bacteri
peptidoglycan
marker
microbi
burden
biolog
activ
substanc
influenc
cellular
immun
respons
manner
differ
endotoxin
high
level
muram
acid
similarli
construct
studi
provid
complimentari
find
lend
credenc
notion
asthma
could
part
due
inadequ
activ
appropri
educ
time
point
innat
immun
respons
stimul
certain
microbi
product
recent
studi
includ
canadian
child
cohort
studi
highlight
import
window
colonis
children
longterm
side
effect
asthma
ensu
presenc
lack
certain
microorgan
gastrointestin
system
determin
rel
abund
bacteri
genera
faecalibacterium
lachnospira
veillonella
rothia
flvr
appear
notabl
decreas
gut
children
risk
develop
asthma
microorgan
appear
mostli
significantli
differ
group
month
differ
decreas
children
reach
year
age
suggest
presenc
colonis
window
opportun
also
seen
preval
gut
microbiota
import
metabolit
deriv
short
chain
fatti
acid
scfa
propion
acet
demonstr
murin
model
reduc
airway
cellular
infiltr
concept
window
opportun
colonis
gener
accept
requir
investig
mice
critic
window
occur
first
week
life
expect
human
critic
window
narrow
first
expect
rather
year
like
mere
last
matter
month
germfre
mice
shown
olszak
et
al
dysregul
develop
immun
cell
profil
microbi
exposur
howev
colonis
gastrointestin
crucial
neonat
period
microbiom
protect
effect
exagger
inflamm
develop
effect
could
demonstr
recolonis
adult
mice
henc
one
might
postul
microbi
exposur
allevi
prevent
immun
cascad
seen
allerg
disord
asthma
could
prebiot
probiot
protect
even
prevent
role
asthma
seen
lactobacillu
reuteri
administ
mice
demonstr
normal
microbi
flora
abat
airway
hyperrespons
via
system
increas
regulatori
cell
therefor
allevi
asthma
symptom
seen
also
direct
exposur
innocu
strain
escherichia
coli
could
result
long
term
protect
allerg
disord
normal
mice
reprogram
macrophag
dendrit
cell
dendrit
cell
bridg
gap
innat
adapt
immun
balbc
ovalbumin
challeng
mice
fed
daili
bifidobacterium
longum
note
airway
inflamm
attenu
reduct
bal
eosinophilia
bal
fluid
protein
bal
cell
mrna
level
observ
test
effect
earli
life
antibiot
exposur
microbiota
subsequ
allerg
asthma
suscept
russel
et
al
treat
neonat
mice
clinic
dose
vancomycin
streptomycin
chang
resid
gut
microbiota
subsequ
asthma
suscept
document
mice
treat
streptomycin
signific
effect
upon
microbiota
asthma
risk
howev
mice
treat
vancomycin
note
reduct
microbi
divers
chang
bacteri
popul
composit
observ
lead
heighten
risk
asthma
develop
upon
allerg
challeng
neither
antibiot
effect
upon
adult
mice
one
might
infer
hygien
hypothesi
relev
neonat
shift
microbi
divers
composit
russel
et
al
investig
whether
effect
held
true
perinat
antibiot
treat
mice
risk
develop
hypersensit
pneumon
h
h
mediat
lung
diseas
contrari
previou
find
sever
diseas
increas
dramat
streptomycin
conclud
perinat
antibiot
affect
resid
gut
microbiota
highli
select
manner
lead
chang
suscept
h
h
h
driven
lung
inflammatori
diseas
preval
helicobact
pylori
domin
bacteria
stomach
strong
matern
transmiss
decreas
possibl
protect
effect
bacteria
seem
asthma
develop
studi
shown
childhood
acquisit
h
pylori
reduc
risk
allergi
asthma
develop
countri
nearli
adult
harbour
gastric
bacterium
h
pylori
industrialis
countri
preval
much
lower
industrialis
countri
unit
state
fewer
children
year
age
colonis
h
pylori
howev
note
h
pylori
acquisit
appear
associ
adult
onset
asthma
suggest
pathogen
risk
factor
adult
onset
asthma
may
differ
childhood
asthma
believ
microaspir
occur
healthi
individu
higher
preval
asthmat
could
part
explain
presenc
oral
microbiota
lower
lung
howev
fulli
explain
individu
higher
rel
abund
certain
bacteria
origin
upper
respiratori
tract
recent
studi
marri
et
al
induc
sputum
sampl
mild
activ
asthmat
nonasthmat
cohort
adult
examin
determin
sputum
sampl
contain
main
bacteri
genera
firmicut
proteobacteria
actinobacteria
make
sequenc
read
shown
proteobacteria
level
elev
asthmat
firmicut
actinobacteria
common
nonasthmat
cohort
studi
determin
mild
asthma
similar
microbi
composit
sever
asthmat
nonasthmat
group
disappear
microbiota
hypothesi
contend
becom
less
colonis
ancient
commens
microorgan
aid
multitud
process
vitamin
uptak
immun
becom
suscept
attack
potenti
pathogen
microorgan
shift
individu
microbi
balanc
may
detriment
consequ
disappear
microbiota
hypothesi
studi
relat
increas
decreas
preval
sever
diseas
develop
nation
hygien
hypothesi
highlight
suscept
infect
caus
decreas
sampl
microorgan
environ
disappear
microbiota
hypothesi
suggest
suscept
due
decreas
ancestr
microorgan
offer
protect
role
gut
microbiota
shape
mucos
immun
system
symbiosi
gut
microbiota
intestin
mucosa
import
barrier
function
within
gut
well
understood
remain
pauciti
inform
pertain
lung
lung
directli
expos
environ
epithelium
first
line
defenc
infect
fact
lung
largest
epitheli
surfac
bodi
produc
inflammatori
product
cytokin
growth
factor
chemokin
lipid
mediat
peptid
mediat
reactiv
oxygennitrogen
speci
respiratori
epitheli
cell
regul
inflammatori
respons
airway
epithelium
act
barrier
prevent
inhal
pathogen
gain
access
club
type
ii
alveolar
epitheli
cell
produc
surfact
effect
trap
pathogen
mucociliari
clearanc
aid
pathogen
remov
epithelium
function
catabol
barrier
proteas
peptid
epithelium
express
cell
surfac
peptidas
produc
proteas
inhibitor
epithelium
barrier
function
augment
integr
tight
junction
protein
cell
innat
immun
respons
includ
macrophag
neutrophil
monocyt
utilis
pathogen
recognit
molecul
prm
recognis
pathogen
associ
molecular
pattern
pamp
lead
product
antimicrobi
product
well
known
cell
surfac
receptor
includ
tolllik
receptor
recognis
wide
varieti
viral
bacteri
pamp
lp
asthma
heterogen
diseas
airway
inflamm
induc
epitheli
exposur
allergen
pollut
microb
stimul
underli
apc
antigen
present
cell
cell
induc
immun
respons
epitheli
exposur
result
predominantli
eosinophil
neutrophil
cell
influx
airway
allerg
subtyp
respond
environmet
allergen
characteris
increas
eosinophil
basophil
mast
cell
along
expans
helper
cell
h
cell
subtyp
epitheli
mucos
barrier
allergen
present
breakdown
physic
barrier
site
allergen
present
propag
allerg
inflammatori
respons
inde
fungal
spore
potent
allergen
postul
damag
epitheli
barrier
induc
cell
shrinkag
subsequ
inflamm
barrier
breakdown
interact
apc
epithelium
critic
event
result
immun
respons
dendrit
cell
act
sentinel
react
exposur
certain
allergen
pathogen
environ
dendrit
cell
activ
appropri
immun
respons
exposur
allergen
depend
appropri
mechan
action
clear
invad
pathogen
note
mice
lack
dc
major
defici
antibacteri
antivir
antifung
immun
recent
murin
studi
believ
epithelium
key
role
activ
dendrit
cell
exposur
advers
pathogen
allergen
establish
epitheliadendrit
cell
commun
pathway
alveolar
macrophag
primari
microbi
sampl
clearanc
mechan
within
lung
lumen
play
integr
role
pulmonari
host
defens
posit
interfac
mucosa
extern
environ
composit
microbiom
asthmat
lung
consequenti
effect
macrophag
sampl
inde
function
alveolar
macrophag
may
also
effect
microb
persist
lung
henc
influenc
result
airway
microbiom
studi
alveolar
macrophag
smoker
demonstr
accumul
tobacco
smoke
particul
lysosom
effect
migrat
respons
mycobacterium
tuberculosi
observ
also
note
regard
asthmat
lung
microbiota
failur
effeci
clear
certain
speci
may
result
persist
imbal
epidemiolog
studi
across
five
contin
span
three
decad
reveal
strong
link
respiratori
infect
pathogenesi
asthma
respiratori
syncyti
viru
rsv
metapneumoviru
coronaviru
parainfluenza
human
rhinoviru
plethora
human
virus
known
connect
respiratori
diseas
like
asthma
human
rhinovirus
act
trigger
asthma
exacerb
viral
respiratori
tract
infect
commonli
rhinoviru
infect
seriou
effect
asthmat
patient
peopl
risk
develop
asthma
caus
exacerb
worsen
diseas
prognosi
emerg
evid
shown
individu
asthma
may
defici
antivir
activ
dysfunct
epitheli
barrier
increas
susceptib
sever
viral
respiratori
infect
potenti
exacerb
sigur
et
al
determin
acut
rsv
infect
occur
conjuct
famili
histori
asthma
synergist
increas
risk
asthma
develop
invidu
illustr
genebyenviron
interact
prognost
implic
asthma
virus
seen
predispos
individu
secondari
bacteri
infect
upon
exposur
rsv
increas
adher
streptococcu
pneumonia
human
epitheli
cell
respiratori
viru
infect
markedli
increas
emerg
room
admiss
relat
asthma
exacerb
wheez
respiratori
viral
ill
birth
year
age
high
risk
children
parent
test
posit
respiratori
allergi
histori
diagnos
asthma
increas
risk
asthma
develop
fold
child
reach
year
age
also
shown
sever
respiratori
syncyti
viru
bronchiol
infanc
predispos
develop
adult
asthma
respiratori
viru
rv
rsv
capabl
activ
rang
proinflammatori
cytokin
chemokin
growth
factor
adhes
molecul
mucin
relev
pathophysiolog
asthma
bacteri
microbiom
lung
main
focu
research
date
howev
fungal
microbiomemycobiom
lung
warrant
investig
marker
fungal
exposur
extracellular
polysaccharid
deriv
aspergillu
penicillium
known
invers
associ
asthma
recent
investig
pool
sputum
sampl
asthma
patient
control
identifi
fungal
speci
speci
common
asthmat
psathyrella
candolleana
malassezia
pachydermati
termitomyc
clypeatu
grifola
sordulenta
commonli
found
asthmat
eremothecium
sinecaudum
systenostrema
alba
cladosporium
cladosporioid
vanderwaltozyma
polyspora
preval
sputum
sampl
control
group
wheeler
et
al
demonstr
antifung
drug
caus
fungal
dysbiosi
mice
dysbiosi
result
increas
sever
airway
inflammatori
diseas
asthma
well
recognis
centuri
mould
exposur
lead
exacerb
asthma
certain
patient
mould
exposur
detriment
effectslead
increas
diseas
sever
hospit
admiss
increas
risk
bronchial
reactiv
death
environment
risk
factor
pollen
anim
dander
mould
spore
impact
asthma
examin
cohort
asthmat
rang
age
year
chicago
us
discov
time
greater
chanc
asthma
relat
death
day
mould
spore
count
reach
spore
per
cubic
meter
factor
genet
patient
socioeconom
situat
import
role
appear
tempor
relationship
high
environment
spore
count
subsequ
asthma
attack
summerautumn
period
asthma
admiss
death
correspond
peak
environment
mould
spore
seen
time
report
black
et
al
patient
admit
icu
acut
asthma
attack
test
posit
skin
test
fungal
spore
includ
alternaria
tenui
cladosporium
cladosporid
epicoccum
nigrum
helminthosporium
maydi
driscol
et
al
recruit
patient
age
year
age
divid
three
group
sever
moder
mild
depend
number
lifetim
hospit
admiss
patient
sever
asthma
test
posit
skin
test
toon
mould
includ
aspergillu
fumigatu
penicillium
notatum
cladosporium
herbarum
alternaria
alternata
yeast
candida
albican
comparison
lower
rate
posit
patient
moder
mild
asthma
exposur
fungal
allergen
devast
impact
onasthmat
fungi
contain
protein
detriment
airway
epithelium
enhanc
addit
reaction
also
act
allergen
possibl
long
term
fungal
colonis
atop
patient
may
provid
chronic
sourc
allergen
exposur
propag
airway
inflamm
increas
sever
asthma
phenotyp
emerg
consensu
microbiom
potenti
play
critic
role
diseas
develop
includ
pathogenesi
airway
condit
asthma
asthma
rate
increas
thank
metagenom
techniqu
possibl
defin
composit
microb
lung
possibl
determin
whether
chang
composit
lower
airway
microbiota
influenc
complex
pathophysiolog
chronic
lung
diseas
asthma
emerg
studi
demonstr
role
gut
lung
microbiota
result
immun
engag
ignor
studi
asthma
diseas
progress
recent
studi
demonstr
oral
antibiot
antimycot
alter
gut
microbiota
exacerb
allerg
asthma
symptom
mice
result
reduct
gut
microbi
divers
modif
popul
composit
found
lead
increas
allerg
symptom
modif
commens
microbi
speci
clostridia
speci
implic
observ
inde
clostridi
dervi
scfa
butyr
actet
respons
induc
mucos
treg
different
function
studi
date
suggest
disrupt
microbiota
shift
individu
microbi
balanc
could
possibl
detriment
effect
research
requir
fulli
dissect
role
ultim
pave
way
emerg
new
therapeut
strategi
combat
condit
